[go: up one dir, main page]

SI1362864T1 - Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli - Google Patents

Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli

Info

Publication number
SI1362864T1
SI1362864T1 SI200330844T SI200330844T SI1362864T1 SI 1362864 T1 SI1362864 T1 SI 1362864T1 SI 200330844 T SI200330844 T SI 200330844T SI 200330844 T SI200330844 T SI 200330844T SI 1362864 T1 SI1362864 T1 SI 1362864T1
Authority
SI
Slovenia
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
SI200330844T
Other languages
English (en)
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SI1362864T1 publication Critical patent/SI1362864T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200330844T 2003-06-30 2003-06-30 Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli SI1362864T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291600A EP1362864B1 (fr) 2003-06-30 2003-06-30 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
SI1362864T1 true SI1362864T1 (sl) 2007-08-31

Family

ID=29266055

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330844T SI1362864T1 (sl) 2003-06-30 2003-06-30 Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli

Country Status (19)

Country Link
US (1) US7220776B2 (sl)
EP (1) EP1362864B1 (sl)
JP (1) JP4347342B2 (sl)
CN (1) CN100383159C (sl)
AR (1) AR044943A1 (sl)
AT (1) ATE360638T1 (sl)
AU (1) AU2004255899B2 (sl)
CY (1) CY1106471T1 (sl)
DE (1) DE60313391T2 (sl)
DK (1) DK1362864T3 (sl)
EA (1) EA009458B1 (sl)
ES (1) ES2286393T3 (sl)
MY (1) MY136938A (sl)
NZ (1) NZ544004A (sl)
PL (1) PL211491B1 (sl)
PT (1) PT1362864E (sl)
SI (1) SI1362864T1 (sl)
WO (1) WO2005005461A2 (sl)
ZA (1) ZA200510324B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551952A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole daao inhibitors
EP1987828A1 (en) 2005-01-06 2008-11-05 IPCA Laboratories Limited salts of perindopril and their use in the therapy of hypertension
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
WO2007081542A2 (en) 2006-01-06 2007-07-19 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
RU2470011C2 (ru) 2007-05-31 2012-12-20 Сепракор Инк. Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
ATE294814T1 (de) * 2003-03-12 2005-05-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
SI1367061T1 (sl) * 2003-06-30 2006-04-30 Servier Lab Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli

Also Published As

Publication number Publication date
EA200501900A1 (ru) 2006-06-30
HK1089187A1 (zh) 2006-11-24
NZ544004A (en) 2009-03-31
US20060148884A1 (en) 2006-07-06
ES2286393T3 (es) 2007-12-01
CN100383159C (zh) 2008-04-23
PL379630A1 (pl) 2006-10-30
CY1106471T1 (el) 2012-01-25
US7220776B2 (en) 2007-05-22
AR044943A1 (es) 2005-10-12
DE60313391T2 (de) 2008-01-17
JP2008500263A (ja) 2008-01-10
CN1805972A (zh) 2006-07-19
EP1362864B1 (fr) 2007-04-25
ZA200510324B (en) 2007-03-28
PL211491B1 (pl) 2012-05-31
JP4347342B2 (ja) 2009-10-21
PT1362864E (pt) 2007-07-23
DK1362864T3 (da) 2007-09-17
WO2005005461A2 (fr) 2005-01-20
DE60313391D1 (de) 2007-06-06
AU2004255899A1 (en) 2005-01-20
WO2005005461A3 (fr) 2005-03-31
MY136938A (en) 2008-11-28
ATE360638T1 (de) 2007-05-15
EA009458B1 (ru) 2007-12-28
EP1362864A1 (fr) 2003-11-19
AU2004255899B2 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
AU4847001A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
AU2001248470A1 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
SI1420028T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1362864T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1367061T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1348684T1 (sl) Nov postopek sinteze (2s)-indolin-2-karboksilne kisline in uporaba pri sintezi perindoprila
SI1380590T1 (sl) Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli
SI1371659T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1420029T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1380591T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
SI1367062T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1367063T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1422236T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
SI1403275T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1753720T1 (sl) Postopek za pripravo perindoprila in njegovih soli
SI1268424T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
HK1089179A (en) Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines